✦ LIBER ✦

Phase I/II study of gemcitabine with pegylated liposomal doxorubicin as first-line therapy in Asian women with metastatic breast cancer

✍ Scribed by Zee-Wan Wong; Peter Cher-Siang Ang; Balram Chowbay; Nan-Soon Wong; Hui-Ti See; Kei-Siong Khoo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First line therapy with paclitaxel (Taxo

✍ D.A Vorobiof; B.L Rapoport; M.R Chasen; C Slabber; G McMichael; R Eek; C Mohamme 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Pegylated Liposomal Doxorubicin and Cycl

✍ Beth Overmoyer; Paula Silverman; Larry W. Holder; Debasish Tripathy; I. Craig He 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 493 KB

A multicentre Phase II study of non-pegy

✍ M. Venturini; C. Bighin; F. Puglisi; N. Olmeo; E. Aitini; G. Colucci; O. Garrone 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 262 KB

Non-pegylated liposomal doxorubicin comb

✍ S. Del Barco; R. Colomer; L. Calvo; I. Tusquets; E. Adrover; P. Sánchez; J. Rifà 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 220 KB

Pegylated liposomal doxorubicin and gemc

✍ Adamo, V; Lorusso, V; Rossello, R; Adamo, B; Ferraro, G; Lorusso, D; Condemi, G; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 126 KB

Pegylated liposomal doxorubicin in combi

✍ Alessandra Fabi; Gianluigi Ferretti; Paola Papaldo; Nello Salesi; Mariangela Cic 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 242 KB